Login / Signup

Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.

Jeffrey P KahnLeslie Meltzer HenryAnna C MastroianniWilbur H ChenRuth Macklin
Published in: Proceedings of the National Academy of Sciences of the United States of America (2020)
Keyphrases
  • sars cov
  • endothelial cells
  • induced pluripotent stem cells
  • respiratory syndrome coronavirus
  • pluripotent stem cells
  • case control